Science goes beyond the lab. It’s driven by people who push boundaries and work together to make progress possible. We empower employees to share ideas, take risks and collaborate across teams so we can meet the needs of patients and create a healthier world for all. #GileadLife
About us
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
- Website
-
http://www.gilead.com
External link for Gilead Sciences
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Foster City, CA
- Type
- Public Company
Locations
Employees at Gilead Sciences
-
john milam
-
Brad Margolis, Ph.D.
Talent Management & Development | Accelerating Strategic Growth | Leadership, Organization & Team Effectiveness | Breakthrough Performance
-
Michele Chase Kashap, MBA
Global Biotechnology Commercial Leader
-
Susan Jameson
Administrative Coordinator at Gilead Sciences
Updates
-
Gilead Sciences reposted this
Senior Vice President, Clinical Development, Virology Therapeutic Area Head at Gilead Sciences
-
We're proud to have supported the #EACS2025 pre-conference ‘Planning for the Now: Access Roadmap for Long-Acting PrEP for Key Populations of Color in Europe’. Co-hosted by Africa Advocacy Foundation and Global Black Gay Men Connect, and involving over 100 stakeholders similarly passionate about shaping the future of HIV prevention in Europe, the event elevated important conversations around country priorities, innovations in prevention and structural barriers to care. Through open dialogue and combined efforts we’re helping to drive positive change in HIV, strengthening networks, advancing equity and supporting prevention. As a founding member of the newly launched HIV Prevention Alliance, we look forward to future knowledge exchange and collective action to help end the HIV epidemic.
-
-
Our vision is bold: to change the future of cancer care. Kasia (Katarzyna Skrzypczynska)'s determination is just one inspiring example embodying how we’re disrupting cancer and redefining what’s possible.
How Kasia Takes Back Possibility
-
#GileadNews: At #IDWeek2025 Gilead will showcase new data from our antiviral research & development portfolio. Learn about our ongoing commitment to addressing the evolving needs of people and communities affected by HIV, hepatitis and respiratory viruses: gilead.inc/42KZtIG
-
#GileadNews: At #ESMO25, we’re presenting positive data from our Phase 3 ASCENT-03 study. These results, also published in NEJM Group, build on Phase 3 data from ASCENT-04 to potentially position our therapy as the first and only antibody-drug conjugate (ADC) to be a backbone standard of care option for all first-line metastatic #TNBC patients, regardless of PD-L1 status. This could mark a major advancement for treating this patient population with historically limited options. http://gilead.inc/43q4AxW
See How We’re Committed to Advancing Innovative Therapies
-
Young Survival Coalition's powerful #YSCWordstoLiveBy campaign inspires us to transform the way cancer is treated in young adults with metastatic breast cancer. Together, we’re addressing gaps in care to improve and expand support for this community. #BCAM Hear more stories: http://gilead.inc/4opvGxq
Metastatic Breast Cancer Stories
-
We step away from #EACS2025 invigorated as we pursue innovation in the laboratory, the clinic and the community. Together, we can work toward addressing the diverse needs of individuals and communities affected by HIV. Through collaboration, we can help bridge gaps in awareness and improve linkage to and retention in care. By working in partnership, we’re helping draw closer to ending the HIV epidemic for everyone, everywhere.
-
Employee Resource Groups are at the heart of life at Gilead. We recently hosted our annual ERG Summit, with the theme of “Choose to Include & Evolve Together” — a chance for our ERG Chairs and Executive Sponsors to connect, collaborate and shape the future of inclusion. #GileadLife
-
-
Women in Europe — especially those from migrant populations — represent a higher proportion of new #HIV cases and are less likely to disclose their status and seek support. During #EACS2025, we talk to women bucking this trend, who share how their experience with HIV has motivated them to advocate for other women. Listen to their stories. https://gilead.inc/3KTwfRK
Women Living with HIV Help Redefine Long-Term Treatment Success